Compare MYGN & UP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYGN | UP |
|---|---|---|
| Founded | 1991 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Aerospace |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 547.2M | 564.7M |
| IPO Year | 1995 | N/A |
| Metric | MYGN | UP |
|---|---|---|
| Price | $5.11 | $0.67 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $10.67 | N/A |
| AVG Volume (30 Days) | 945.4K | ★ 8.9M |
| Earning Date | 02-23-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $825,300,000.00 | $757,468,000.00 |
| Revenue This Year | $0.05 | $174.46 |
| Revenue Next Year | $5.54 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.21 | N/A |
| 52 Week Low | $3.76 | $0.56 |
| 52 Week High | $15.47 | $3.50 |
| Indicator | MYGN | UP |
|---|---|---|
| Relative Strength Index (RSI) | 27.66 | 39.64 |
| Support Level | $5.03 | $0.56 |
| Resistance Level | $5.70 | $0.65 |
| Average True Range (ATR) | 0.28 | 0.07 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 8.93 | 13.25 |
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.